相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiac safety and potential efficacy: two reasons for considering minocycline in place of azithromycin in COVID-19 management
Giovanni Diana et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19
Milo Gatti et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
A novel approach to managing COVID-19 patients: results of lopinavir plus doxycycline cohort-authors' reply
Yasemin Cag et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory
Maurizio Carcaterra et al.
MEDICAL HYPOTHESES (2021)
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients
Apurva Hariharan et al.
INFLAMMOPHARMACOLOGY (2021)
Tetracycline and viruses: a possible treatment for COVID-19?
Jesus A. Mosquera-Sulbaran et al.
ARCHIVES OF VIROLOGY (2021)
Immunomodulatory Effect of Doxycycline Ameliorates Systemic and Pulmonary Inflammation in a Murine Polymicrobial Sepsis Model
Anasuya Patel et al.
INFLAMMATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?
Camillo Sargiacomo et al.
AGING-US (2020)
Doxycycline, a widely used antibiotic in dermatology with a possible anti-inflammatory action against IL-6 in COVID-19 outbreak
Claudio Conforti et al.
DERMATOLOGIC THERAPY (2020)
Phylogenetic network analysis of SARS-CoV-2 genomes
Peter Forster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Tocilizumab treatment in COVID-19: A single center experience
Pan Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Thromboinflammation and the hypercoagulability of COVID-19
Jean M. Connors et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Telemedicine in the Era of COVID-19
Jay Portnoy et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Therapeutic Potential for Tetracyclines in the Treatment of COVID-19
Mohit Sodhi et al.
PHARMACOTHERAPY (2020)
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
Bradley J. Langford et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges
Harmanjit Singh et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2020)
Severe COVID-19: NLRP3 Inflammasome Dysregulated
Daan F. van den Berg et al.
FRONTIERS IN IMMUNOLOGY (2020)
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
Rafael B. Polidoro et al.
FRONTIERS IN IMMUNOLOGY (2020)
Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2
Sounik Manna et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
Bacterial co-infections withSARS-CoV-2
Rasoul Mirzaei et al.
IUBMB LIFE (2020)
Concomitant infection with COVID-19 and Mycoplasma pneumoniae
Allen Chung-Cheng Huang et al.
BIOMEDICAL JOURNAL (2020)
Doxycycline: From Ocular Rosacea to COVID-19 Anosmia. New Insight Into the Coronavirus Outbreak
Chiara Bonzano et al.
FRONTIERS IN MEDICINE (2020)
Postulated Adjuvant Therapeutic Strategies for COVID-19
Anderson O. Ferreira et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Extrapulmonary manifestations of COVID-19
Aakriti Gupta et al.
NATURE MEDICINE (2020)
Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches
Deep Bhowmik et al.
INFECTION GENETICS AND EVOLUTION (2020)
Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure
T. Ueland et al.
JOURNAL OF INFECTION (2020)
Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations
Shiv Bharadwaj et al.
LIFE SCIENCES (2020)
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection
Shashank Shekhar Gautam et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)
Would Repurposing Minocycline Alleviate Neurologic Manifestations of COVID-19?
Aline C. Oliveira et al.
FRONTIERS IN NEUROSCIENCE (2020)
Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19?
Masashi Ohe et al.
BIOSCIENCE TRENDS (2020)
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Ralf Kircheis et al.
FRONTIERS IN IMMUNOLOGY (2020)
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
Mathieu Gendrot et al.
MOLECULES (2020)
Clinical Outcomes of Early Treatment With Doxycycline for 89 High-Risk COVID-19 Patients in Long-Term Care Facilities in New York
Mohammud M. Alam et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data
Sohini Chakraborti et al.
MOLECULAR OMICS (2020)
Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease
Paul A. Yates et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2020)
Tetracyclines: light-activated antibiotics?
Michael R. Hamblin et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
Andre C. Ferreira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Minocycline protects against myocardial ischemia/reperfusion injury in rats by upregulating MCPIP1 to inhibit NF-κB activation
Quan Yi et al.
ACTA PHARMACOLOGICA SINICA (2019)
L-NAME improves doxycycline and ML-7 cardioprotection from oxidative stress
Iwona Bil-Lula et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Doxycycline enhances adsorption and inhibits early-stage replication of porcine reproductive and respiratory syndrome virus in vitro
Yuming Li et al.
FEMS MICROBIOLOGY LETTERS (2017)
Biochar based removal of antibiotic sulfonamides and tetracyclines in aquatic environments: A critical review
Chathuri Peiris et al.
BIORESOURCE TECHNOLOGY (2017)
Anti-Inflammatory Properties of Low and High Doxycycline Doses: An In Vitro Study
Roberta Di Caprio et al.
MEDIATORS OF INFLAMMATION (2015)
Tetracyclines Disturb Mitochondrial Function across Eukaryotic Models: A Call for Caution in Biomedical Research
Norman Moullan et al.
CELL REPORTS (2015)
Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis
Manoj Kumar Mishra et al.
JOURNAL OF NEUROCHEMISTRY (2008)
分享论文
